CBDA does not make you high. It lacks the ability to bind to the brain receptors responsible for the intoxicating effects of THC, so it produces no euphoria, altered perception, or psychoactive buzz. CBDA (cannabidiolic acid) is the raw, unheated precursor to CBD found naturally in hemp and cannabis plants, and like CBD, it is non-intoxicating.
Why CBDA Doesn’t Produce a High
The “high” from cannabis comes from THC locking onto CB1 receptors in the brain. This triggers the familiar effects: euphoria, altered time perception, increased appetite, and cognitive changes. CBDA does not activate CB1 receptors in a meaningful way. Instead, it works through entirely different pathways in the body, primarily influencing serotonin receptors involved in mood and nausea regulation.
Research published in the British Journal of Pharmacology found that CBDA enhances the activation of 5-HT1A serotonin receptors, the same receptors targeted by certain anti-nausea and anti-anxiety medications. In animal studies, CBDA suppressed nausea-related behavior at remarkably low doses (as little as 0.01 mg per kilogram of body weight), and these effects were blocked when the serotonin receptor was chemically shut off. This confirms that CBDA’s primary mechanism of action has nothing to do with the cannabinoid receptors responsible for intoxication.
CBDA vs. CBD: Key Differences
CBDA is the “raw” form of CBD. Living hemp plants don’t actually contain much CBD at all. They produce CBDA, which only converts into CBD when exposed to heat. This conversion, called decarboxylation, happens completely at around 140°C (284°F) over 30 to 60 minutes. Smoking, vaping, or baking cannabis triggers this process. If you eat raw hemp flower or take a product specifically marketed as containing CBDA, you’re getting the acid form before it transforms.
One major practical difference: CBDA is absorbed far more efficiently than CBD when taken orally. A human pharmacokinetic study found that peak blood concentrations of CBDA were 19 to 25 times higher than CBD, and CBDA reached those peak levels up to twice as fast. This means you may need a much smaller dose of CBDA to achieve similar effects compared to CBD. Researchers also found that CBDA was significantly more potent than CBD at reducing nausea in animal models.
What CBDA Actually Feels Like
Because CBDA doesn’t bind to CB1 receptors, you won’t feel “stoned” or mentally impaired. What some people do report are subtle effects related to its serotonin activity: mild relaxation, reduced queasiness, or a general sense of calm. These are not intoxicating effects.
The most commonly reported side effects from cannabidiol-type compounds (CBD and CBDA) in clinical settings include drowsiness, mild sedation, changes in appetite, and occasional digestive issues like diarrhea. Altered mood has also been noted. None of these effects resemble a THC high, though the sedation could be noticeable, especially at higher doses.
The THC Contamination Risk
Here’s the important caveat: while CBDA itself won’t get you high, some CBDA products might contain enough THC to produce mild intoxication. Under the 2018 Farm Bill, hemp-derived products are legal as long as the source plant contains no more than 0.3% THC by dry weight. But that limit applies to the raw plant material, not necessarily the concentrated finished product sitting on a store shelf.
Research analyzing commercially available CBD products has found that many contain appreciable concentrations of THC, sometimes enough to cause unexpected impairment. Full-spectrum CBDA products are especially likely to contain trace THC because they’re designed to preserve the plant’s full range of compounds. A human laboratory study testing a full-spectrum product with a 1:1 ratio of CBDA to CBD found that even a relatively low THC dose (averaging 7.2 mg) in the highest-dose group produced moderate cognitive impairment and subjective feelings of intoxication.
If you want to avoid any possibility of a high, look for broad-spectrum or isolate CBDA products that have been third-party tested with a certificate of analysis showing THC levels below the detection limit.
Potential Drug Interactions
CBDA is closely related to CBD, and CBD is a potent inhibitor of liver enzymes responsible for breaking down roughly 80% of common medications. While the research on CBDA specifically is still limited, CBD has been shown to interfere with the same enzyme family used to metabolize blood thinners, certain heart medications, anti-seizure drugs, and many others. Because CBDA converts partially into CBD in the body and shares structural similarities, caution is warranted if you take prescription medications. The higher bioavailability of CBDA could amplify this concern, since more of the compound reaches your bloodstream per dose.
Legal Status
CBDA derived from hemp (containing no more than 0.3% THC) is federally legal in the United States under the 2018 Farm Bill. The FDA retains authority over how hemp products are marketed and sold, which means CBDA products still need to comply with food and supplement safety standards. State laws vary, so the legality of purchasing and possessing CBDA products depends on where you live. Because CBDA is non-intoxicating on its own, it faces fewer regulatory hurdles than THC-containing products in most jurisdictions.